Suwon-si, South Korea

Ji Hee Ha


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Suwon-si, KR (2021)
  • Daegu, KR (2020 - 2023)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ji Hee Ha: Innovator in Heterodimeric Fc-Fused Proteins

Introduction

Ji Hee Ha is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of heterodimeric Fc-fused proteins. With a total of 5 patents to his name, his work has the potential to impact various therapeutic applications.

Latest Patents

One of Ji Hee Ha's latest patents is focused on a heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the same. This invention relates to a heterodimeric Fc-fused protein that includes a first Fc region and a second Fc region of an immunoglobulin Fc pair. The protein is composed of two or more different subunits, with one or more subunits linked to the N-terminus or C-terminus of the Fc regions. The CH3 domains of these Fc regions are mutated to promote heterodimeric Fc formation. This innovative approach allows the physiologically active protein to maintain its natural form and structure, enhancing its in vivo half-life and physiological activity.

Career Highlights

Ji Hee Ha is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he continues to advance his research in biotechnology. His work is characterized by a commitment to developing novel therapeutic solutions that leverage the unique properties of heterodimeric proteins.

Collaborations

Ji Hee Ha collaborates with notable colleagues, including Yong Sung Kim and Hye Ji Choi, who contribute to his research endeavors. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Ji Hee Ha's contributions to the field of biotechnology, particularly through his patents on heterodimeric Fc-fused proteins, highlight his role as a leading inventor. His work promises to enhance therapeutic applications and improve patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…